Synthesis of 4 - aryl substituted semicarbazones and their terpenes derivatives: A newer scaffold as an anticonvulsant agents

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 5, 2011, Pages 456-464

  Pandeya, S N ^a   Khan, Ahsan Ahmed ^a   Srivastava, Anupam ^a  

^a Saroj Institute of Technology and Management   (India)

Author keywords

Anticonvulsant activity; Sedative hypnotic activity; Semicarbazone derivatives; Terpenes

Indexed keywords

1 METHYL BICYCLO[2,2,1]HEPTAN 2 ONE N (4 BROMOPHENYL)SEMICARBAZONE ETHANE; 1 METHYL BICYCLO[2,2,1]HEPTAN 2 ONE N (4 CHLOROPHENYL)SEMICARBAZONE ETHANE; 1 METHYL BICYCLO[2,2,1]HEPTAN 2 ONE N (4 NITROPHENYL)SEMICARBAZONE ETHANE; 2 ISOPROPYL 5 METHYL CYCLOHEXAN 1 ONE N (4 BROMOPHENYL)SEMICARBAZONE; 2 ISOPROPYL 5 METHYL CYCLOHEXAN 1 ONE N (4 CHLOROPHENYL)SEMICARBAZONE; 2 ISOPROPYL 5 METHYL CYCLOHEXAN 1 ONE N (4 NITROPHENYL)SEMICARBAZONE; 3,7 DIMETHYL OCTA 2,6 DIENAL N (4 BROMOPHENYL)SEMICARBAZONE; 3,7 DIMETHYL OCTA 2,6 DIENAL N (4 CHLOROPHENYL)SEMICARBAZONE; 3,7 DIMETHYL OCTA 2,6 DIENAL N (4 NITROPHENYL)SEMICARBAZONE; 4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; DIAZEPAM; ISONIAZID; PENTOBARBITAL; PHENYTOIN; SEMICARBAZONE DERIVATIVE; TERPENE DERIVATIVE; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CONVULSION; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; RIGHTING REFLEX; ROTAROD TEST; SEDATION; SINGLE DRUG DOSE; SLEEP TIME;

EID: 80053516804     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ho, B., Crider, A.M., Stables, J.P. Eur.J.Med Chem., 2001 36: 265 - 286.
2. Craig, C. R. Anticonvulsant Drugs. In: Craig, C. R., Stitzel, R.E. (Eds.), Modern Pharmacology with Clinical Application. 5th edition, Little Brown and Company, New York, 1997, 391-405.
3. Willmore, L.J. Epilepsy Behav. 2005; 7 (suppl. 3): 25-28.
4. Pandeya, S.N., Mishra, V., Acta Pharm. 2001 51, 183-188.
5. Singhal, M.; Paul, A; Singh, H.P; Dubey, S.K.; Gaur, K; J. Chem. Pharm. Res., 2011, 3 (3): 639-645.
6. Rajasekaran, S.; Rao, G.K.; Pai, S.; Sodhi, G.S.; J.Chem.Pharm.Res., 2010, 2 (1), 482-488.
7. Dimmock, J.R., Puthucode, R.N., Smith, J.M., J. Med Chem. 1996, 39(20), 3984-3997.
8. Pandeya, S.N., Mishra, V., Singh, P.N. Pharmacological Res.1998, 37, 17-22.
9. Pandeya, S.N., Mishra, V., Stable, J.P, Polish J. Pharmacol. 2000, 52, 283-290.
10. Pandeya, S.N., Sowmayalakshmi, V., Panda, S. S., Pandey, A., Stable, J. P. Anticonvulsant activity of semicarbazone derivatives of Mannich bases. Indian J Chem. 2003, 42B, 2657-2661.
11. Pandeya, S.N., Raja, A.S. and Stable, J.P. J. Pharm. Pharmaceut. Sci., 2002, 5 (3), 266-271.
12. Vogel, H.G., Drug discovery and evaluation: pharmacological assays, Berlin: Springer Verlag, New York, 2002, 696-716.
13. Lioscher, U., Breg, H.H., Arch. Pharmacol., 1977, 296 (3), 263-269.
14. Nishie, K., Weary, M., Berger, A. The J. Pharmacol. Exp. Thera., 1996, 153 (3), 387-395.
15. Wada, J.A., Asakura, T., Exp. Neuro., 1969, 24 (1), 19-37.
16. Yamaguchi, S.I., Rogawski, M.A. Epilepsy Res, 1992, 11, 9-16.
17. Oyama, Y., Brain Res., 1987, 409 (2), 243-249.
18. Krall, R.L., Penry, J.K., White, B.G., Kupferberg, H.J., Swinyard, E.A. Antiepileptic drug development II; Anticonvulsant drug screening. Epilepsia, 1978; 19, 409-28.
19. Grafe, P., Galvan, M., Bruggencate, G, Brain Res., 1982, 241, 75-86.
20. Bhragual, D.D., Kumar, N., Drabu, S. J.Chem.Pharm.Res., 2010, 2 (2), 345-349.
21. Pandeya, S.N., Aggarwal, N., Jain, J.S., Pharmazie,1999, 54, 4, 300-302.